Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
复制标题
DOI:
10.1093/carcin/bgn091
复制
发表时间:
2008-07
期刊:
影响因子:
4.7
通讯作者:
Lee YM
中科院分区:
文献类型:
--
作者:
Cheng W;Tseng CJ;Lin TT;Cheng I;Pan HW;Hsu HC;Lee YM
Glypican-3 (gpc3) is the gene responsible for Simpson-Golabi-Behmel overgrowth syndrome. Previously, we have shown that GPC3 is overexpressed in hepatocellular carcinoma (HCC). In this study, we demonstrated the mechanisms for GPC3-mediated oncogenesis. Firstly, GPC3 overexpression in NIH3T3 cells gave to cancer cell phenotypes including growing in serum-free medium and forming colonies in soft agar, or on the other way, GPC3 knockdown in HuH-7 cells decreased oncogenecity. We further demonstrated that GPC3 bound specifically through its N-terminal proline-rich region to both Insulin-like growth factor (IGF)-II and IGF-1R. GPC3 stimulated the phosphorylation of IGF-1R and the downstream signaling molecule extracellular signal-regulated kinase (ERK) in an IGF-II-dependent way. Also, GPC3 knockdown in HCC cells decreased the phosphorylation of both IGF-1R and ERK. Therefore, GPC3 confers oncogenecity through the interaction between IGF-II and its receptor, and the subsequent activation of the IGF-signaling pathway. This data are novel to the current understanding of the role of GPC3 in HCC and will be important in future developments of cancer therapy.
登录
查看更多内容
影响因子:
8.3
作者:
Abdallah BM
通讯作者:
Abdallah BM
影响因子:
6.4
作者:
Hishinuma, M.;Ohashi, K-I;Fukayama, M.
通讯作者:
Fukayama, M.
影响因子:
5.3
作者:
KALEKO, M;RUTTER, WJ;MILLER, AD
通讯作者:
MILLER, AD
影响因子:
8
作者:
Kitisin, K.;Ganesan, N.;Mishra, L.
通讯作者:
Mishra, L.
影响因子:
6.5
作者:
Kim, HJ;Kim, TY
通讯作者:
Kim, TY